1. Home
  2. ENTX vs PSQH Comparison

ENTX vs PSQH Comparison

Compare ENTX & PSQH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTX
  • PSQH
  • Stock Information
  • Founded
  • ENTX 2010
  • PSQH 2021
  • Country
  • ENTX Israel
  • PSQH United States
  • Employees
  • ENTX N/A
  • PSQH N/A
  • Industry
  • ENTX Biotechnology: Biological Products (No Diagnostic Substances)
  • PSQH Advertising
  • Sector
  • ENTX Health Care
  • PSQH Consumer Discretionary
  • Exchange
  • ENTX Nasdaq
  • PSQH Nasdaq
  • Market Cap
  • ENTX 67.2M
  • PSQH 75.3M
  • IPO Year
  • ENTX 2018
  • PSQH N/A
  • Fundamental
  • Price
  • ENTX $2.25
  • PSQH $4.03
  • Analyst Decision
  • ENTX Strong Buy
  • PSQH Strong Buy
  • Analyst Count
  • ENTX 1
  • PSQH 1
  • Target Price
  • ENTX $10.00
  • PSQH $3.50
  • AVG Volume (30 Days)
  • ENTX 54.3K
  • PSQH 11.5M
  • Earning Date
  • ENTX 11-08-2024
  • PSQH 11-12-2024
  • Dividend Yield
  • ENTX N/A
  • PSQH N/A
  • EPS Growth
  • ENTX N/A
  • PSQH N/A
  • EPS
  • ENTX N/A
  • PSQH N/A
  • Revenue
  • ENTX $99,000.00
  • PSQH $18,738,575.00
  • Revenue This Year
  • ENTX N/A
  • PSQH $320.53
  • Revenue Next Year
  • ENTX N/A
  • PSQH $56.41
  • P/E Ratio
  • ENTX N/A
  • PSQH N/A
  • Revenue Growth
  • ENTX 607.14
  • PSQH 482.62
  • 52 Week Low
  • ENTX $0.52
  • PSQH $2.00
  • 52 Week High
  • ENTX $3.35
  • PSQH $7.77
  • Technical
  • Relative Strength Index (RSI)
  • ENTX 68.35
  • PSQH 55.38
  • Support Level
  • ENTX $2.02
  • PSQH $4.00
  • Resistance Level
  • ENTX $2.28
  • PSQH $4.76
  • Average True Range (ATR)
  • ENTX 0.17
  • PSQH 0.79
  • MACD
  • ENTX 0.04
  • PSQH 0.01
  • Stochastic Oscillator
  • ENTX 77.01
  • PSQH 37.37

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

About PSQH PSQ Holdings Inc.

PSQ Holdings Inc operates the website and mobile application named as PublicSq. It is an app and website that connects freedom-loving Americans to high-quality businesses that share values, both online and in local communities. The primary mission of the platform is to help consumers "shop their values" and put purpose behind purchases. It has two reportable segments comprised of Marketplace; which includes a marketplace platform to access consumers that are drawn to patriotic values and the revenue is generated in the form of advertising and eCommerce transactions, and Brands segment in which through its wholly-owned brand, the company generates revenue from online sales of diapers and wipes.

Share on Social Networks: